Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension

201780 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 76, Issue 11, pp. 1931-1940

Field-Weighted Citation Impact: 6.88